SCHEMBL5713076

SCHEMBL5713076

Nc1cc(Cl)c(Sc2nc3cc(Cl)ccc3s2)c(CC=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ ALOX5 P09917 3/20 0.43
▸ PPARA Q07869 7/20 0.41
▸ LOXL2 Q9Y4K0 1/20 0.40
▸ GLB1 P16278 1/20 0.40
▸ CTRC Q99895 1/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ MEN1 O00255 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ HPGD P15428 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ HSP90AB1 P08238 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ PSMD14 O00487 1/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7576875 0.86 ALOX5 (0.41) SMN1; SMN2NPSR1ALOX5PPARAKMT2A
SCHEMBL5713090 0.84 PPARA (0.44) SMN1; SMN2NPSR1ALOX5PPARAGLB1
SCHEMBL12585006 0.80 SMN1; SMN2 (0.55) SMN1; SMN2NPSR1ALOX5PPARALOXL2
SCHEMBL2034875 0.78 PPARA (0.49) SMN1; SMN2NPSR1ALOX5PPARAGLB1
SCHEMBL12584997 0.76 SMN1; SMN2 (0.58) SMN1; SMN2NPSR1ALOX5PPARALOXL2
SCHEMBL5713084 0.74 MAPT (0.40) SMN1; SMN2NPSR1PPARAKMT2AALDH1A1
SCHEMBL7569633 0.72 MAPT (0.40) SMN1; SMN2NPSR1ALOX5PPARAKMT2A
SCHEMBL8564013 0.72 SMN1; SMN2 (0.59) SMN1; SMN2NPSR1ALOX5PPARALOXL2
SCHEMBL12584982 0.71 MAPT (0.45) SMN1; SMN2NPSR1ALOX5PPARAGLB1
SCHEMBL2030702 0.71 ILK (0.44) SMN1; SMN2NPSR1ALOX5PPARAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1722789-A2 THERAPEUTIC MODULATION OF PPAR (GAMMA) ACTIVITY Amgen Inc. (US) 2006-11-22 — — EP disclosed
WO-2005086904-A2 THERAPEUTIC MODULATION OF PPAR (GAMMA) ACTIVITY AMGEN INC. (US) 2005-09-22 — — WO disclosed
EP-1192137-A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY Tularik Inc. (US) 2002-04-03 — — EP disclosed
WO-2001000579-A1 COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY TULARIK INC. (US) 2001-01-04 — — WO disclosed
Send feedback